Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of pre- and post-ischemic treatments with FK409, a nitric oxide donor, on ischemia/reperfusion-induced renal injury and endothelin-1 production in rats.
Nakajima A, Ueda K, Takaoka M, Kurata H, Takayama J, Ohkita M, Matsumura Y. Nakajima A, et al. Among authors: ueda k. Biol Pharm Bull. 2006 Mar;29(3):577-9. doi: 10.1248/bpb.29.577. Biol Pharm Bull. 2006. Retraction in: Biol Pharm Bull. 2014;37(6):1080. doi: 10.1248/bpb.b14-e3706 PMID: 16508172 Free article. Retracted.
Preventive effect of SA13353 [1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea], a novel transient receptor potential vanilloid 1 agonist, on ischemia/reperfusion-induced renal injury in rats.
Ueda K, Tsuji F, Hirata T, Ueda K, Murai M, Aono H, Takaoka M, Matsumura Y. Ueda K, et al. J Pharmacol Exp Ther. 2009 Apr;329(1):202-9. doi: 10.1124/jpet.108.146241. Epub 2009 Jan 15. J Pharmacol Exp Ther. 2009. Retraction in: J Pharmacol Exp Ther. 2014 May;349(2):346. doi: 10.1124/jpet.114.05er14b PMID: 19147859 Retracted.
A prospective comparison of implant quality between suture-coated seeds and uncoated seeds in prostate cancer brachytherapy.
Nakiri M, Ogasawara N, Kurose H, Ueda K, Suekane H, Chikui K, Nishihara K, Uemura K, Ejima K, Hoshino R, Onishi S, Komiya K, Muraki K, Hattori C, Ogo E, Ishitake T, Igawa T. Nakiri M, et al. Among authors: ueda k. J Contemp Brachytherapy. 2024 Oct;16(5):315-322. doi: 10.5114/jcb.2024.144175. Epub 2024 Oct 16. J Contemp Brachytherapy. 2024. PMID: 39719952 Free PMC article.
Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial.
Kuzumi A, Oba K, Ebata S, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Kage H, Sato S, Yoshizaki A. Kuzumi A, et al. Among authors: ueda k. Rheumatology (Oxford). 2024 Dec 24:keae716. doi: 10.1093/rheumatology/keae716. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39718799
Prediction of Hepatocellular Carcinoma After Hepatitis C Virus Sustained Virologic Response Using a Random Survival Forest Model.
Nakahara H, Ono A, Hayes CN, Shirane Y, Miura R, Fujii Y, Murakami S, Yamaoka K, Bao H, Uchikawa S, Fujino H, Murakami E, Kawaoka T, Miki D, Tsuge M, Oka S; Hiroshima Liver Study Group; TransSCOT Consortium. Nakahara H, et al. JCO Clin Cancer Inform. 2024 Dec;8:e2400108. doi: 10.1200/CCI.24.00108. Epub 2024 Dec 18. JCO Clin Cancer Inform. 2024. PMID: 39693579
5,561 results